National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
Y 90 Zevalin (... ZEV-uh-lin)

 A radiolabeled monoclonal antibody that is used to treat certain types of B-cell non-Hodgkin lymphoma and is being studied in the treatment of other types of B-cell tumors. It is made up of the monoclonal antibody ibritumomab plus the radioisotope yttrium Y 90. It binds to the protein called CD20, which is found on B cells. The radiation in the yttrium Y 90 may kill the cancer cells. Y 90 Zevalin is a type of radiopharmaceutical. Also called yttrium Y 90 ibritumomab tiuxetan, Y 90 ibritumomab tiuxetan, and IDEC-Y2B8.

Previous Definitions:XL880, XR9576, XRP9881, Xyotax, Y 90 ibritumomab tiuxetan
Next Definitions:yangona, yin and yang, YKL-40, YM598, yoga